128 related articles for article (PubMed ID: 9480114)
1. [Resuscitation necessitated by a transfusion reaction after HLA mismatched platelets substitution].
Kuntz BM; Schöttler B; Brüster HT
Beitr Infusionsther Transfusionsmed; 1994; 32():307-9. PubMed ID: 9480114
[TBL] [Abstract][Full Text] [Related]
2. How much residual plasma may cause TRALI?
Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
[TBL] [Abstract][Full Text] [Related]
3. Platelet transfusion refractoriness due to graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation.
Taaning E; Jacobsen N
Transplant Proc; 1994 Jun; 26(3):1826. PubMed ID: 8030157
[No Abstract] [Full Text] [Related]
4. Post-transfusion purpura caused by anti-HPA-3a antibodies that are only detectable using whole platelets in the platelet immunofluorescence test.
Barba P; Pallarés P; Nogués N; Canals C; Gracia M; Vinyets I; Muñiz-Diaz E
Transfus Med; 2010 Jun; 20(3):200-2. PubMed ID: 19919615
[No Abstract] [Full Text] [Related]
5. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
[TBL] [Abstract][Full Text] [Related]
6. Platelet refractoriness due to combined anti-HLA and anti-HPA-5a alloantibodies: clinical management during myeloablative allogeneic HSCT and development of a quantitative MAIPA assay.
Arber C; Bertrand G; Halter J; Boehlen F; Kaplan C; Gratwohl A
Br J Haematol; 2007 Oct; 139(1):159-61. PubMed ID: 17854320
[No Abstract] [Full Text] [Related]
7. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
Toor AA; Choo SY; Little JA
Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
[TBL] [Abstract][Full Text] [Related]
8. [Labile blood products from donors immunized against the HLA system. Apropos of a case of transfusional pulmonary edema].
Fruchart MF; Belhocine R; Klaren J; Ben Hadj Amor H; Fretz C
Transfus Clin Biol; 1998 Dec; 5(6):381-4. PubMed ID: 9894328
[TBL] [Abstract][Full Text] [Related]
9. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support.
Moazami N; Itescu S; Williams MR; Argenziano M; Weinberg A; Oz MC
J Heart Lung Transplant; 1998 Sep; 17(9):876-80. PubMed ID: 9773859
[TBL] [Abstract][Full Text] [Related]
10. [Transfusion of leukocytes and platelets in the treatment of acute leukemia].
Baklaja R; Stajić M; Banicević B; Jancić M; Cvetković V; Maslovarić S; Susaković N; Andelić M; Stefanović S
Bilt Hematol Transfuz; 1978; 6(3):31-8. PubMed ID: 295220
[TBL] [Abstract][Full Text] [Related]
11. Neonatal alloimmune thrombocytopenia due to anti-human leukocyte antigen antibody: a case report.
Sasaki M; Yagihashi A; Kobayashi D; Watanabe N; Fujikawa T; Chiba S; Sato S; Morishita K; Sekimoto T; Ikeda H
Pediatr Hematol Oncol; 2001 Dec; 18(8):519-24. PubMed ID: 11764101
[TBL] [Abstract][Full Text] [Related]
12. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
[TBL] [Abstract][Full Text] [Related]
13. Autologous platelet collection and storage to support thrombocytopenia in patients undergoing high-dose chemotherapy and circulating progenitor cell transplantation for high-risk breast cancer.
Torretta L; Perotti C; Pedrazzoli P; Dornini G; Viarengo G; Livraghi A; Noris P; Da Prada GA; Balduini CL; della Cuna GR; Salvaneschi L
Vox Sang; 1998; 75(3):224-9. PubMed ID: 9852411
[TBL] [Abstract][Full Text] [Related]
14. [Thrombocyte substitution in acute leukemia. Effect of histocompatibility on the clinical efficacy].
Kubel M; Freistedt B; Hammer P; Thierbach V; Helbig W; Haustein B; Schultze W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):355-64. PubMed ID: 6179839
[TBL] [Abstract][Full Text] [Related]
15. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
16. [Transfusion of platelet concentrates].
Rieux C; Lee K; Lavaud A; Bierling P
Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
[TBL] [Abstract][Full Text] [Related]
17. Non-HLA antibodies after rejection of HLA identical kidney transplants.
Zafar MN; Terasaki PI; Naqvi SA; Rizvi SA
Clin Transpl; 2006; ():421-6. PubMed ID: 18365399
[TBL] [Abstract][Full Text] [Related]
18. Leukaemia cutis in a patient treated for breast cancer.
Weinel S; Malone J; Jain D; Callen JP
Australas J Dermatol; 2009 Feb; 50(1):52-5. PubMed ID: 19178494
[TBL] [Abstract][Full Text] [Related]
19. Hyperacute rejection after lung transplantation caused by undetected low-titer anti-HLA antibodies.
Masson E; Stern M; Chabod J; Thévenin C; Gonin F; Rebibou JM; Tiberghien P
J Heart Lung Transplant; 2007 Jun; 26(6):642-5. PubMed ID: 17543791
[TBL] [Abstract][Full Text] [Related]
20. Effective desensitization of donor-specific HLA antibodies using platelet transfusion bearing targeted HLA in a case of HLA-mismatched allogeneic stem cell transplantation.
Yamashita T; Ikegame K; Kojima H; Tanaka H; Kaida K; Inoue T; Ogawa H
Bone Marrow Transplant; 2017 May; 52(5):794-796. PubMed ID: 28165448
[No Abstract] [Full Text] [Related]
[Next] [New Search]
